Why Respiratory and Sleep Labs Across the NHS Are Rethinking Their Software in 2026
NHS respiratory and sleep labs are under more pressure than ever in 2026. Between evolving clinical standards, growing patient volumes, and the NHS's own push toward digital transformation, the legacy systems many labs have relied on for years are struggling to keep up. The question is no longer whether to modernise lab software, but how to do it without disrupting the clinical work that cannot stop.
TL;DR
The NHS is actively shifting toward digital, cloud-based tools for respiratory and sleep care, driven by national strategy and clinical need.
Remote monitoring and digital health are reshaping how labs interact with patients and manage data.
Outdated, siloed software creates clinical risk, inefficiency, and compliance headaches.
Labs are looking for vendor-neutral, integrated platforms that reduce administrative burden without replacing clinical judgment.
Rezibase is a cloud-based respiratory and sleep reporting system built by respiratory scientists, already trusted by NHS sites.
About the Author: This article was written by the team at Rezibase, a specialist respiratory and sleep reporting platform with over 37 years of combined experience in clinical physiology. Rezibase is used across NHS hospitals, NSW Health facilities, and private labs across Australia, New Zealand, the UK, and Ireland.
What Is Driving Software Change in NHS Respiratory and Sleep Labs Right Now?
Three forces are converging simultaneously in 2026: national health policy, rising demand for remote and digital care, and the maturation of cloud-based clinical tools.
The NHS 10-Year Health Plan, published in July 2025, explicitly prioritises the shift from analogue to digital systems across the health service [6]. That is not background noise for respiratory and sleep departments. It is a direct mandate. Labs still running on-premise, single-vendor systems that cannot integrate with hospital-wide infrastructure are increasingly out of step with the direction NHS leadership has set.
At the same time, demand for respiratory and sleep services is not shrinking. COPD, sleep apnoea, and interstitial lung disease all require ongoing monitoring, regular reporting cycles, and coordination across clinical teams. Software that creates bottlenecks in any of those workflows adds real clinical risk, not just inconvenience.
How Is Digital Health Changing Respiratory Care in Hospitals?
Digital health tools are no longer a peripheral add-on to respiratory medicine. A 2025 narrative review published in PMC examined how digital health is being applied across respiratory conditions including COPD and ILD, finding that digital tools are being used across diagnosis, monitoring, patient education, and clinical decision-making [3]. The review highlighted the growing body of evidence supporting the clinical integration of digital solutions in respiratory management.
Separately, a rapid qualitative evaluation from NCBI Bookshelf looked at the real-world implementation of technology-enabled remote monitoring (TERM) for COPD patients, noting that apps and connected devices are actively helping patients monitor and manage their condition outside of hospital settings [1]. For labs, this creates both an opportunity and a challenge: the data pipeline from patient to clinician is expanding, and the software sitting at the centre of a lab needs to handle that complexity.
Key shifts happening right now across NHS respiratory care:
Remote monitoring tools generating new data streams that need to be captured and interpreted in lab systems
Patient-facing digital tools increasing the volume of touchpoints between labs and patients
AI-assisted diagnostic tools being piloted in adjacent specialties, including a March 2026 initiative using AI to assist NHS clinicians in identifying childhood sleep apnoea [2]
Curriculum and competency reviews being completed for respiratory and sleep science to reflect new technology use [4]
Why Are Legacy Systems Becoming a Clinical Risk?
A legacy system in a respiratory lab is not just an inconvenience. It is a source of compounding clinical and operational risk.
Problem | Impact |
|---|---|
Double data entry | Increased error rate, wasted scientist time |
Vendor lock-in | Restricted device choice, outdated normal values |
No cloud access | Cannot support remote work or multi-site operations |
Poor EMR integration | Data silos, incomplete patient records |
Manual accreditation tracking | Compliance gaps, audit exposure |
When a lab is manually re-entering data from testing devices into a separate reporting system, every transcription is a potential error. When a system only works with one device manufacturer, labs lose the flexibility to choose the best equipment for their patients. When reporting software cannot communicate with the hospital's EMR or Patient Administration System, clinicians are working with incomplete pictures.
What Does the NHS Actually Need from Respiratory Lab Software in 2026?
In December 2025, NHS SBS published details of a new framework agreement specifically designed to help respiratory patients stay well at home, with the framework including remote monitoring, home re-supply, and compliance reporting features to ease pressure on NHS clinics [5]. This signals a clear direction: NHS procurement is actively seeking tools that reduce in-clinic burden while maintaining clinical rigour.
What labs are asking for:
Vendor neutrality: The ability to import data from any device manufacturer without being locked into a proprietary ecosystem
Cloud access: Software that works anywhere, without server management overhead for hospital IT teams
Integrated workflows: Connections to PAS, EMR, DICOM worklists, and ordering systems
Accreditation support: Built-in tools to manage documents, audits, quality control, and non-conformances to TSANZ/NATA and ISO 15189 standards
AI-assisted reporting: Structured, guideline-aligned outputs that reduce report writing time without removing clinical oversight
What Is Involved in Switching Respiratory Lab Software?
Switching software sounds daunting, but the actual process is more straightforward than most labs expect. The key is choosing a platform designed for migration, not one that makes it difficult.
A practical transition typically involves:
Data review: Identifying what patient and report data needs to be carried forward
System configuration: Setting up normal values, report templates, and integration connections to match your lab's workflows
Staff orientation: Getting scientists and reporting clinicians comfortable with the new interface
Go-live support: Running the new system alongside the old for a short overlap period if needed
Platforms built with migration in mind handle the heavy lifting. For labs switching to Rezibase from a previous system, the process is designed to be handled collaboratively, with the team supporting configuration so scientists are not starting from scratch. The cloud-based architecture means there is no server infrastructure to migrate, and the vendor-neutral import tools mean existing device data can come across cleanly.
Why Are NHS Labs Choosing Rezibase?
Rezibase was built by respiratory scientists Peter Rochford and the late Jeff Pretto, which means the platform reflects the actual daily workflows of clinical physiology rather than a software developer's interpretation of them. That origin matters: features like the Magic Import function (which automatically extracts discrete data including flow-volume loops directly from device reports), the pre-configured Normal Values Library, and the AI-assisted structured reporting tools exist because scientists asked for them.
For NHS labs specifically, Rezibase offers enterprise-grade deployment options, full integration with NHS hospital systems, and an accreditation module that covers everything needed to meet TSANZ/NATA and ISO 15189 standards. The pricing model is transparent and all-inclusive with no lock-in contracts, which aligns with the NHS's need for predictable, auditable procurement.
Frequently Asked Questions
Is Rezibase currently used in the NHS?
Yes. Rezibase is already trusted by NHS sites in the UK, alongside facilities within NSW Health in Australia.
Does Rezibase work with any respiratory device manufacturer?
Yes. Rezibase is vendor-neutral and manufacturer-agnostic, meaning it can import data from any device type regardless of manufacturer.
How long does it take to implement Rezibase in a hospital lab?
Implementation timelines vary by site complexity, but the cloud-based architecture and collaborative onboarding process are designed to get labs up and running efficiently without lengthy IT projects.
Does Rezibase support accreditation requirements?
Yes. The platform includes a dedicated accreditation module covering documents, training records, non-conformances, action plans, audits, and quality control to meet TSANZ/NATA and ISO 15189 standards.
Can Rezibase integrate with our existing hospital systems?
Yes. Rezibase integrates with Patient Administration Systems, EMR systems, DICOM Modality Worklists, hospital finance systems, and electronic ordering systems.
Does Rezibase cover both respiratory and sleep reporting?
Yes. Unlike many platforms that cover only one specialty, Rezibase is built to manage both respiratory and sleep science workflows within the same system.
Is there a trial available before committing?
Yes. Rezibase offers a 30-day free trial with no lock-in contract.
About Rezibase
Rezibase is a cloud-based respiratory and sleep reporting platform designed by and for respiratory scientists, with over 37 years of combined experience in clinical physiology. Used across more than 35 sites including NHS hospitals and NSW Health facilities, Rezibase is a vendor-neutral, fully integrated solution covering everything from patient referrals and device data import through to AI-assisted reporting, accreditation management, and hospital system integration. The platform is backed by Cardiobase, a healthcare technology company committed to solving real clinical problems, with transparent pricing and no lock-in contracts.
If your respiratory or sleep lab is evaluating its software options in 2026, the Rezibase team is available to walk you through a demonstration and answer site-specific questions. Visit rezibase.com to learn more or start your free trial.
References
Implementation and use of technology-enabled remote monitoring for chronic obstructive pulmonary disease: a rapid qualitative evaluation - NCBI Bookshelf (www.ncbi.nlm.nih.gov)
AI Advancements in Diagnosing Childhood Sleep Apnea (sleepworldmagazine.com)
The role of digital health in respiratory diseases management: a narrative review of recent literature - PMC (pmc.ncbi.nlm.nih.gov)
Respiratory and Sleep Science – 2025 review results — Curriculum review (nshcs.hee.nhs.uk)
New framework helps respiratory patients stay well at home this winter | NHS SBS (www.sbs.nhs.uk)
Fit for the future: 10 Year Health Plan for England (accessible version) - GOV.UK (www.gov.uk)